The Board of Directors of Aurobindo Pharma Ltd at its meeting held on June 17, 2022, had approved the acquisition of 51% equity shares in GLS Pharma Limited, operating in oncology business and having manufacturing facility in Hyderabad for a total consideration of Rs. 28.05 crores.
The Company has completed the aforesaid acquisition of 51% of equity share capital of GLS Pharma Limited on August 17, 2022 and it has now become the subsidiary of the Company.
Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 580.40 as compared to the previous close of Rs. 583.85. The total number of shares traded during the day was 45055 in over 1867 trades.
The stock hit an intraday high of Rs. 591.10 and intraday low of 577.55. The net turnover during the day was Rs. 26253919.00.